These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29637413)

  • 21. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
    Andreelli F; Amouyal C; Magnan C; Mithieux G
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):499-507. PubMed ID: 20152734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet.
    Nyavor Y; Estill R; Edwards H; Ogden H; Heideman K; Starks K; Miller C; May G; Flesch L; McMillan J; Gericke M; Forney L; Balemba O
    Cell Tissue Res; 2019 Jun; 376(3):325-340. PubMed ID: 30778729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does 'metabolic surgery' work its magic? New evidence for gut microbiota.
    Peck BCE; Seeley RJ
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):81-86. PubMed ID: 29337705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?
    Chondronikola M; Harris LL; Klein S
    J Intern Med; 2016 Nov; 280(5):476-486. PubMed ID: 27739136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.
    Batterham RL; Cummings DE
    Diabetes Care; 2016 Jun; 39(6):893-901. PubMed ID: 27222547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal changes after bariatric surgery.
    Quercia I; Dutia R; Kotler DP; Belsley S; Laferrère B
    Diabetes Metab; 2014 Apr; 40(2):87-94. PubMed ID: 24359701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature.
    Sweeney TE; Morton JM
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):727-40. PubMed ID: 25194186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis.
    Mithieux G
    Nutrition; 2009 Sep; 25(9):881-4. PubMed ID: 19647621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery.
    Mäkinen J; Hannukainen JC; Karmi A; Immonen HM; Soinio M; Nelimarkka L; Savisto N; Helmiö M; Ovaska J; Salminen P; Iozzo P; Nuutila P
    Diabetologia; 2015 May; 58(5):1055-62. PubMed ID: 25631620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bariatric surgery for type 2 diabetes: to whom and when?
    Samaras K
    Minerva Endocrinol; 2013 Mar; 38(1):47-58. PubMed ID: 23435442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.
    Aron-Wisnewsky J; Prifti E; Belda E; Ichou F; Kayser BD; Dao MC; Verger EO; Hedjazi L; Bouillot JL; Chevallier JM; Pons N; Le Chatelier E; Levenez F; Ehrlich SD; Dore J; Zucker JD; Clément K
    Gut; 2019 Jan; 68(1):70-82. PubMed ID: 29899081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bariatric surgery and the gut-brain communication--the state of the art three years later.
    Diniz Mde F; Azeredo Passos VM; Diniz MT
    Nutrition; 2010 Oct; 26(10):925-31. PubMed ID: 20392599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Hormone Mechanisms of Bariatric Surgery.
    Dimitriadis GK; Randeva MS; Miras AD
    Curr Obes Rep; 2017 Sep; 6(3):253-265. PubMed ID: 28780756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions.
    Haluzík M; Kratochvílová H; Haluzíková D; Mráz M
    J Endocrinol; 2018 Apr; 237(1):R1-R17. PubMed ID: 29378901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical considerations for the management of residual diabetes following bariatric surgery.
    Kashyap SR; Schauer P
    Diabetes Obes Metab; 2012 Sep; 14(9):773-79. PubMed ID: 22288474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reoperative bariatric surgery for treatment of type 2 diabetes mellitus.
    Yan J; Cohen R; Aminian A
    Surg Obes Relat Dis; 2017 Aug; 13(8):1412-1421. PubMed ID: 28647410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bariatric surgery and nonalcoholic fatty liver disease.
    Bower G; Athanasiou T; Isla AM; Harling L; Li JV; Holmes E; Efthimiou E; Darzi A; Ashrafian H
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):755-68. PubMed ID: 25919774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.
    Caparrós-Martín JA; Lareu RR; Ramsay JP; Peplies J; Reen FJ; Headlam HA; Ward NC; Croft KD; Newsholme P; Hughes JD; O'Gara F
    Microbiome; 2017 Aug; 5(1):95. PubMed ID: 28793934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.